Patent directory Β· USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12208071
Glucagon receptor antagonists
granted -
CN 119365549
Fluorescent probe targeting CA-IX
granted -
WO 2025018295
BACTΓRIOPHAGE MODIFIΓ
granted -
US 12201617
HDAC6 inhibitors for treatment of metabolic disease and HFpEF
granted -
US 12201593
Oral pharmaceutical formulations of bitter compounds for asthma
granted -
US 12201601
Treatment for obesity
granted -
US 12201699
Compositions and methods for promoting homology directed repair
granted -
US 12201685
Methods of modulating immune responses with cationic lipid vaccine compositions
granted -
US 12201683
Methods for preventing dengue and hepatitis a
granted -
US 12203143
Methods and kits to identify Klebsiella strains
granted -
US 12201591
Sustained release compositions of endoxifen
granted -
US 12203106
Compositions for increasing polypeptide stability and activity, and related methods
granted -
US 12202883
Anti-VEGF protein compositions and methods for producing the same
granted -
US 12202886
Neutralizing antibodies to GP120 and their use
granted -
US 12203098
Cells having solid tumor targeting backbone and use thereof
granted -
US 12203072
Chemically modified single-stranded rna-editing oligonucleotides
granted -
US 12201701
Vegetable oil-derived contrast agent with high stability and preparation method thereof
granted -
US 12201721
Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device
granted -
US 12202880
HLA engineering methods and compositions for treatment of autoimmunity
granted -
US 12202822
Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical composition
granted -
US 12202798
Antimicrobial compounds, compositions, and articles of manufacture for selectively inhibiting pathogenic microbes
granted -
US 12202845
Ras inhibitors
granted -
US 12202877
T cell receptors with mage-B2 specificity and uses thereof
granted -
US 12201604
Treatment of circadian rhythm disorders
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β best for looking up a specific filing or applicant portfolio slice.